On November 3, 2023, Sorrento Therapeutics, Inc. completed a reduction in U.S. headcount from 123 to 90.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0137 USD | -31.50% | -31.50% | -88.91% |
Mar. 15 | Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs | MT |
Mar. 12 | News Highlights : Top Company News of the Day - Tuesday at 5 AM ET | DJ |
1st Jan change | Capi. | |
---|---|---|
-88.91% | 7.45M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- SRNE Stock
- News Sorrento Therapeutics, Inc.
- Sorrento Therapeutics, Inc. Completes Reduction in U.S. Headcount from 123 to 90